Literature DB >> 31186882

Risk factors for hepatocellular carcinoma.

D Alan Herbst1, K Rajender Reddy1.   

Abstract

Entities:  

Year:  2013        PMID： 31186882      PMCID： PMC6499296          DOI： 10.1002/cld.111

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


× No keyword cloud information.
  13 in total

1.  World Gastroenterology Organisation Guideline. Hepatocellular carcinoma (HCC): a global perspective.

Authors:  Peter Ferenci; Michael Fried; Douglas Labrecque; J Bruix; M Sherman; M Omata; J Heathcote; T Piratsivuth; Mike Kew; Jesse A Otegbayo; S S Zheng; S Sarin; S Hamid; Salma Barakat Modawi; Wolfgang Fleig; Suliman Fedail; Alan Thomson; Aamir Khan; Peter Malfertheiner; George Lau; F J Carillo; Justus Krabshuis; Anton Le Mair
Journal:  J Gastrointestin Liver Dis       Date:  2010-09       Impact factor: 2.008

2.  Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level.

Authors:  Chien-Jen Chen; Hwai-I Yang; Jun Su; Chin-Lan Jen; San-Lin You; Sheng-Nan Lu; Guan-Tarn Huang; Uchenna H Iloeje
Journal:  JAMA       Date:  2006-01-04       Impact factor: 56.272

3.  Hepatocellular carcinoma in African Blacks: Recent progress in etiology and pathogenesis.

Authors:  Michael C Kew
Journal:  World J Hepatol       Date:  2010-02-27

4.  Global cancer statistics.

Authors:  Ahmedin Jemal; Freddie Bray; Melissa M Center; Jacques Ferlay; Elizabeth Ward; David Forman
Journal:  CA Cancer J Clin       Date:  2011-02-04       Impact factor: 508.702

Review 5.  Chronic hepatitis B and hepatocellular carcinoma.

Authors:  Amy C McClune; Myron J Tong
Journal:  Clin Liver Dis       Date:  2010-08       Impact factor: 6.126

Review 6.  Hepatocellular carcinoma: epidemiology and molecular carcinogenesis.

Authors:  Hashem B El-Serag; K Lenhard Rudolph
Journal:  Gastroenterology       Date:  2007-06       Impact factor: 22.682

7.  Epidemiology of primary hepatic malignancies in U.S. children.

Authors:  Anil Darbari; Keith M Sabin; Craig N Shapiro; Kathleen B Schwarz
Journal:  Hepatology       Date:  2003-09       Impact factor: 17.425

Review 8.  Meta-analysis of epidemiologic studies on cigarette smoking and liver cancer.

Authors:  Yuan-Chin Amy Lee; Catherine Cohet; Yu-Ching Yang; Leslie Stayner; Mia Hashibe; Kurt Straif
Journal:  Int J Epidemiol       Date:  2009-08-31       Impact factor: 7.196

Review 9.  Synergistic interaction between aflatoxin B1 and hepatitis B virus in hepatocarcinogenesis.

Authors:  Michael C Kew
Journal:  Liver Int       Date:  2003-12       Impact factor: 5.828

10.  Management of hepatocellular carcinoma: an update.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425
View more
  11 in total

1.  Postresection Period-Specific Hazard of Recurrence as a Framework for Surveillance Strategy in Patients with Hepatocellular Carcinoma: A Multicenter Outcome Study.

Authors:  Ha Il Kim; Jihyun An; Ji Yoon Kim; Hyun Phil Shin; Seo Young Park; Gi-Won Song; Han Chu Lee; Ju Hyun Shim
Journal:  Liver Cancer       Date:  2021-09-17       Impact factor: 12.430

2.  Treatment Adherence to Nucleos(t)ide Analogs in Chinese Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma: A Single-Center Cross-Sectional Study.

Authors:  Yueyue Li; Anni Chen; Hui Wang; Lu Han; Rong Wang; Guoqing Zhang; Yongfang Yuan
Journal:  Patient Prefer Adherence       Date:  2021-08-10       Impact factor: 2.711

3.  The Incidence Rate of Liver Cancer in Saudi Arabia: An Observational Descriptive Epidemiological Analysis of Data from the Saudi Cancer Registry (2004-2014).

Authors:  Ibrahim G Alghamdi; Mohamed S Alghamdi
Journal:  Cancer Manag Res       Date:  2020-02-13       Impact factor: 3.989

4.  BIR repeat-containing ubiquitin conjugating enzyme (BRUCE) regulation of β-catenin signaling in the progression of drug-induced hepatic fibrosis and carcinogenesis.

Authors:  Chrystelle L Vilfranc; Li-Xiao Che; Krushna C Patra; Liang Niu; Olugbenga Olowokure; Jiang Wang; Shimul A Shah; Chun-Ying Du
Journal:  World J Hepatol       Date:  2021-03-27

5.  Identification of potential microRNA groups for the diagnosis of hepatocellular carcinoma (HCC) using microarray datasets and bioinformatics tools.

Authors:  Vo Hoang Xuan Dat; Bui Thi Huyen Nhung; Nguyen Ngoc Bao Chau; Pham Hung Cuong; Vo Duc Hieu; Nguyen Thi Minh Linh; Nguyen Bao Quoc
Journal:  Heliyon       Date:  2022-02-21

6.  Juvenile Hepatocellular Carcinoma in a Healthy Liver.

Authors:  Sachiyo Onishi; Masahiro Tajika; Tsutomu Tanaka; Keisaku Yamada; Tomoyasu Kamiya; Seiji Natsume; Yasuhiro Shimizu; Yasumasa Niwa
Journal:  Intern Med       Date:  2021-10-19       Impact factor: 1.282

Review 7.  Hepcidin in hepatocellular carcinoma.

Authors:  Jonathan H Joachim; Kosha J Mehta
Journal:  Br J Cancer       Date:  2022-03-09       Impact factor: 9.075

Review 8.  Immunotherapy for advanced hepatocellular carcinoma: From clinical trials to real-world data and future advances.

Authors:  Kathrine S Rallis; Dimitrios Makrakis; Ioannis A Ziogas; Georgios Tsoulfas
Journal:  World J Clin Oncol       Date:  2022-06-24

9.  The association between antibiotic use and outcomes of HCC patients treated with immune checkpoint inhibitors.

Authors:  Lilong Zhang; Chen Chen; Dongqi Chai; Chunlei Li; Yongjun Guan; Li Liu; Tianrui Kuang; Wenhong Deng; Weixing Wang
Journal:  Front Immunol       Date:  2022-08-17       Impact factor: 8.786

Review 10.  Immunotherapy for advanced hepatocellular carcinoma: a focus on special subgroups.

Authors:  Matthias Pinter; Bernhard Scheiner; Markus Peck-Radosavljevic
Journal:  Gut       Date:  2020-08-03       Impact factor: 23.059
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.